8-K 1 d816417d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 12, 2019

 

 

COMMUNITY HEALTH SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-15925   13-3893191

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

4000 Meridian Boulevard

Franklin, Tennessee 37067

(Address of principal executive offices)

Registrant’s telephone number, including area code: (615) 465-7000

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.01 par value   CYH   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 8.01. Other Events.

On November 12, 2019, Community Health Systems, Inc. (the “Company”) and its wholly-owned subsidiary, CHS/Community Health Systems, Inc. (the “Borrower”), entered into Amendment No. 2 (“Amendment No. 2”) to the Borrower’s asset-based loan facility (the “ABL Facility”). Amendment No. 2, among other things, increases the portion of the commitments under the ABL Facility that are available in the form of letters of credit from $50,000,000 to $200,000,000 and designates approximately $145,000,000 in letters of credit outstanding under the Borrower’s existing cash-flow based revolving credit facility (the “Revolving Facility”) as letters of credit outstanding under the ABL Facility. It is a condition to the effectiveness of Amendment No. 2 that the commitments under the Revolving Facility have been terminated and that all indebtedness outstanding under the Revolving Facility has been repaid in full. None of the foregoing amendments or actions will take effect if the Revolving Facility is not terminated. As previously announced by the Company, the Borrower intends to terminate the Revolving Facility in connection with certain previously announced refinancing transactions.

Forward-Looking Statement

This report may include information that could constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risk and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 12, 2019    

COMMUNITY HEALTH SYSTEMS, INC.

          (Registrant)

    By:  

/s/ Thomas J. Aaron

     

Thomas J. Aaron

Executive Vice President and Chief Financial Officer

(principal financial officer)